Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells

被引：218
|
作者：
SchmidtWolf, GD
Negrin, RS
SchmidtWolf, IGH
机构：
[1] HUMBOLDT UNIV BERLIN,VIRCHOW CLIN,DEPT MED,DIV HEMATOL ONCOL,D-13353 BERLIN,GERMANY
[2] STANFORD UNIV,MED CTR,BONE MARROW TRANSPLANTAT PROGRAM,STANFORD,CA 94305
来源：
ANNALS OF HEMATOLOGY | 1997年 / 74卷 / 02期
关键词：
T cells; cytokine-induced killer cells; immunotherapy;
D O I：
10.1007/s002770050257
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Over the past two decades, attempts have been made to develop immunotherapy for patients with cancer. A significant obstacle to the development of successful adoptive immunotherapy has been the availability of appropriate cytotoxic cells. Immunologic effector cells such as lymphokine-activated killer (LAK) cells, activated T cells such as tumor-infiltrating lymphocytes (TILs), and cytokine-induced killer (CIK) cells may be suitable to remove residual tumor cells.
引用
收藏
页码：51 / 56
页数：6
相关论文
共 50 条
  • [31] Role of IL-12 and IL-15 in the ex vivo expansion, cytotoxicity and cytokine production of human CD3(+)CD56(+) cells derived from T cells.
    Lu, PH
    Wang, ZH
    Mehta, B
    Negrin, RS
    BLOOD, 1996, 88 (10) : 21252 - 21252
  • [32] CD4+CD25+ Regulatory T Cells Decreased the Antitumor Activity of Cytokine-Induced Killer (CIK) Cells of Lung Cancer Patients
    Hui Li
    Jin-Pu Yu
    Shui Cao
    Feng Wei
    Peng Zhang
    Xiu-Mei An
    Zong-Tang Huang
    Xiu-Bao Ren
    Journal of Clinical Immunology, 2007, 27 : 317 - 326
  • [33] CD4+CD25+ regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients
    Li, Hui
    Yu, Jin-Pu
    Cao, Shui
    Wei, Feng
    Zhang, Peng
    An, Xiu-Mei
    Huang, Zong-Tang
    Ren, Xiu-Bao
    JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (03) : 317 - 326
  • [34] DIFFERENTIAL-DIAGNOSIS OF CD3(+), CD56(+) T-CELL LEUKEMIAS - RESPONSE
    GENTILE, TC
    LOUGHRAN, TP
    BLOOD, 1995, 85 (06) : 1676 - 1676
  • [35] Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells
    Han, Lu
    Shang, Yi-Man
    Song, Yong-Ping
    Gao, Quan-Li
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [36] Functionally and phenotypically distinct cord blood CD16(+)CD56 natural killer (NK) cells may be precursors of mature CD16(+)CD56(+) NK cells
    Gaddy, J
    Broxmeyer, HE
    BLOOD, 1995, 86 (10) : 2847 - 2847
  • [37] CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C
    Kokordelis, Pavlos
    Kraemer, Benjamin
    Boesecke, Christoph
    Voigt, Esther
    Ingiliz, Patrick
    Glaessner, Andreas
    Wolter, Franziska
    Srassburg, Christian P.
    Spengler, Ulrich
    Rockstroh, Juergen K.
    Nattermann, Jacob
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (04) : 338 - 346
  • [38] Flow Cytometric Evaluation of Surface CD56 Expression on Activated Natural Killer Cells as Functional Marker
    Oboshi, Wataru
    Aki, Kensaku
    Tada, Tomoki
    Watanabe, Toru
    Yukimasa, Nobuyasu
    Ueno, Ichiro
    Saito, Ken
    Hosoi, Eiji
    JOURNAL OF MEDICAL INVESTIGATION, 2016, 63 (3-4): : 199 - 203
  • [39] CD56 is a functional immune receptor for aging T cells
    Montag, D. T.
    Lemster, B. H.
    Michel, J. J.
    Koeske, Z.
    Studenski, S. A.
    Vallejo, A. N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S159 - S159
  • [40] BREFELDIN-A INHIBITS CYTOLYTIC ACTIVITY OF CYTOKINE-ACTIVATED CD3(+) AND CD56(+) CTLS IN-VITRO AGAINST VASCULAR ENDOTHELIAL-CELLS BUT NOT AGAINST TUMOR TARGETS
    HOPPE, EG
    ALVARNAS, J
    NEGRIN, RS
    FASEB JOURNAL, 1995, 9 (04): : A793 - A793
12345